Advertisement
Screener

CONMED CORPORATION (CNMD) Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets

1.9 / 5 stars · 45/116 Roast Me

CONMED CORPORATION Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets

CONMED CORPORATION (CNMD) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets of 7.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets · last filed 2026-02-17

  • CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2025 was 7.00%, a 0.00% change from fiscal 2024.
  • CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2024 was 7.00%, a 0.00% change from fiscal 2023.
  • CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2023 was 7.00%, a 0.00% change from fiscal 2022.
  • CONMED CORPORATION defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2022 was 7.00%, a 0.00% change from fiscal 2021.
Period endDefined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets 12 month
2025-12-317.00%
10-K · filed 2026-02-17
2024-12-317.00%
10-K · filed 2026-02-17
2023-12-317.00%
10-K · filed 2026-02-17
2022-12-317.00%
10-K · filed 2025-02-18
2021-12-317.00%
10-K · filed 2024-02-28
2020-12-317.00%
10-K · filed 2023-02-21
2019-12-317.50%
10-K · filed 2022-02-22
2018-12-317.50%
10-K · filed 2021-02-22
2017-12-318.00%
10-K · filed 2020-02-24
2016-12-318.00%
10-K · filed 2019-02-25
2015-12-318.00%
10-K · filed 2018-02-26
2014-12-318.00%
10-K · filed 2017-02-27
2013-12-318.00%
10-K · filed 2016-02-23
2012-12-318.00%
10-K · filed 2015-02-23
2011-12-318.00%
10-K · filed 2014-02-24
2010-12-318.00%
10-K · filed 2013-02-25
2009-12-318.00%
10-K · filed 2012-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ceribell, Inc. (CBLL)United States$0.916B-11.27
BIOLIFE SOLUTIONS INC (BLFS)United States$1.887B23.80
Axogen, Inc. (AXGN)United States$2.329B-73.83
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B
Neuraxis, INC (NRXS)United States$0.097B